Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Dare Bioscience (DARE) Other Operating Expenses (2016 - 2024)

Dare Bioscience's Other Operating Expenses history spans 6 years, with the latest figure at -$7674.0 for Q4 2024.

  • For Q4 2024, Other Operating Expenses fell 130.7% year-over-year to -$7674.0; the TTM value through Sep 2025 reached -$7674.0, down 123.49%, while the annual FY2023 figure was $100000.0, 0.0% changed from the prior year.
  • Other Operating Expenses reached -$7674.0 in Q4 2024 per DARE's latest filing, down from $7674.0 in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $25000.0 in Q3 2020 to a low of -$7674.0 in Q4 2024.
  • Average Other Operating Expenses over 5 years is $21296.3, with a median of $25000.0 recorded in 2020.
  • Peak YoY movement for Other Operating Expenses: soared 100.0% in 2021, then plummeted 130.7% in 2024.
  • A 5-year view of Other Operating Expenses shows it stood at $25000.0 in 2020, then changed by 0.0% to $25000.0 in 2021, then changed by 0.0% to $25000.0 in 2022, then changed by 0.0% to $25000.0 in 2023, then tumbled by 130.7% to -$7674.0 in 2024.
  • Per Business Quant, the three most recent readings for DARE's Other Operating Expenses are -$7674.0 (Q4 2024), $7674.0 (Q1 2024), and $25000.0 (Q4 2023).